Steve Pieper
Chief Financial Officer
Steve Pieper is the Chief Financial Officer of Xeris Pharmaceuticals, having previously served as Vice President of Finance since he joined the company in 2017. Mr Pieper brings over 20 years of experience working in the life science industry in various financial leadership roles.
Prior to Xeris, Mr. Pieper served as the CFO and COO of Catheter Connections Inc., a company focused on the development and commercialization of innovative vascular access products designed to protect patients from acquiring infections during intravenous infusion therapy. Catheter Connections, Inc. was acquired by Merit Medical in January 2016. Mr. Pieper also held the position of Director of Finance at Durata Therapeutics Inc., a biopharmaceutical company, which was acquired by Actavis (now Allergan) in November 2014. Mr. Pieper started his career in healthcare at Baxter Healthcare Corporation, where he held a variety of commercial and corporate decision support finance roles.
Mr. Pieper received an MBA from Loyola University, Chicago and BS in Finance from DePaul University.
Prior to Xeris, Mr. Pieper served as the CFO and COO of Catheter Connections Inc., a company focused on the development and commercialization of innovative vascular access products designed to protect patients from acquiring infections during intravenous infusion therapy. Catheter Connections, Inc. was acquired by Merit Medical in January 2016. Mr. Pieper also held the position of Director of Finance at Durata Therapeutics Inc., a biopharmaceutical company, which was acquired by Actavis (now Allergan) in November 2014. Mr. Pieper started his career in healthcare at Baxter Healthcare Corporation, where he held a variety of commercial and corporate decision support finance roles.
Mr. Pieper received an MBA from Loyola University, Chicago and BS in Finance from DePaul University.